Dbv Technologies S.A. – American Depositary Shares (NASDAQ:DBVT) Short Interest Strengthened By 14.25%

DBV Technologies S.A. (NASDAQ:DBVT) Corporate Logo

It was noted an increase on Dbv Technologies S.A. – American Depositary Shares (NASDAQ:DBVT)’s short interest with 14.25%. It was published in January by FINRA the 1.55 million short interest on DBVT. The 1.36M previous shares are up with 14.25%. 12 days will cost DBVT with 135,300 average volume to recover its former position. 4.94% is Dbv Technologies S.A. – American Depositary Shares float short.

DBVT reached $7.98 during the last trading session after $0.01 change.Currently DBV Technologies S.A. is downtrending after 34.24% change in last January 14, 2018. DBVT has 118,302 shares volume. The stock underperformed the S&P 500 by 34.24%.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products.The company has $477.13 million market cap. The Company’s lead product candidate is Viaskin Peanut, an immunotherapy product, which is in Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults.Last it reported negative earnings. The firm is also developing Viaskin Milk that is in Phase II clinical trial for the treatment of Immunoglobulin E mediated cowÂ’s milk protein allergy and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of henÂ’s egg allergy; and booster vaccine for Bordatella pertussis.

DBV Technologies S.A. (NASDAQ:DBVT) Ratings Coverage

Total analysts of 6 have positions in DBV Technologies (NASDAQ:DBVT) as follows: 3 rated it a “Buy”, 0 with “Sell” and 3 with “Hold”. The positive are 50%. Since September 11, 2018 according to StockzIntelligence Inc DBV Technologies has 7 analyst reports. On Tuesday, September 11 the firm earned “Equal-Weight” rating by Morgan Stanley. On Thursday, December 20 Jefferies downgraded DBV Technologies S.A. (NASDAQ:DBVT) to “Hold” rating. On Thursday, December 20 the rating was maintained by JMP Securities with “Market Outperform”. On Thursday, December 20 the stock of DBV Technologies S.A. (NASDAQ:DBVT) has “Equal-Weight” rating given by Morgan Stanley. On Friday, November 2 the company was maintained by Bank of America. In Thursday, December 20 report Barclays Capital downgraded it to “Equal-Weight” rating and $8 target.

There’s a substantial DBV Technologies S.A. (NASDAQ:DBVT) news announced by Benzinga.com. It’s an article titled: “60 Biggest Movers From Yesterday – Benzinga” on December 21, 2018.

DBV Technologies S.A. (NASDAQ:DBVT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.